BIOMAT Database Logo BIOMAT Database Logo

[Use of rosanol in chronic cholecystoangiocholitis]. 1982

T M Galetskaia, and E A Ivanova, and K A Mironova, and B K Reĭngardt, and A M Spivak

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D002761 Cholangitis Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both. Cholangitides
D002764 Cholecystitis Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases. Empyema, Gallbladder,Gallbladder Inflammation,Empyema, Gall Bladder,Gall Bladder Empyema,Gallbladder Empyema,Inflammation, Gallbladder
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females

Related Publications

T M Galetskaia, and E A Ivanova, and K A Mironova, and B K Reĭngardt, and A M Spivak
[EKG changes in chronic cholecystoangiocholitis].
June 1974, Klinicheskaia meditsina,
T M Galetskaia, and E A Ivanova, and K A Mironova, and B K Reĭngardt, and A M Spivak
[Levomycin therapy of chronic cholecystoangiocholitis].
October 1958, Terapevticheskii arkhiv,
T M Galetskaia, and E A Ivanova, and K A Mironova, and B K Reĭngardt, and A M Spivak
[The use of oxygen and multivitamins in the complex treatment of chronic cholecystoangiocholitis patients].
June 1967, Vrachebnoe delo,
T M Galetskaia, and E A Ivanova, and K A Mironova, and B K Reĭngardt, and A M Spivak
[Condition of the colon in patients with chronic cholecystoangiocholitis].
February 1973, Vrachebnoe delo,
T M Galetskaia, and E A Ivanova, and K A Mironova, and B K Reĭngardt, and A M Spivak
[Coagulation and anticoagulation system of blood in chronic cholecystoangiocholitis].
November 1974, Vrachebnoe delo,
T M Galetskaia, and E A Ivanova, and K A Mironova, and B K Reĭngardt, and A M Spivak
[Effect of physical exercise during drug therapy of chronic cholecystoangiocholitis (clinicophysiological study)].
January 1970, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
T M Galetskaia, and E A Ivanova, and K A Mironova, and B K Reĭngardt, and A M Spivak
[Treatment of chronic cholecystitis and cholecystoangiocholitis with a new Russian preparation oxaphenamide].
June 1961, Klinicheskaia meditsina,
T M Galetskaia, and E A Ivanova, and K A Mironova, and B K Reĭngardt, and A M Spivak
[The effect of oxygen therapy on certain liver function in patients with chronic hepatitis and cholecystoangiocholitis].
October 1969, Vrachebnoe delo,
T M Galetskaia, and E A Ivanova, and K A Mironova, and B K Reĭngardt, and A M Spivak
[EXPERIENCE IN THE USE OF HYDROGEN SULFIDE WATER FROM SOCHI-MATSESTA TORPID CHOLECYSTOANGIOCHOLITIS AS AN ASSOCIATED DISEASE].
January 1965, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
T M Galetskaia, and E A Ivanova, and K A Mironova, and B K Reĭngardt, and A M Spivak
[Secretory function of the stomach in patients with pulmonary tuberculosis associated with ulcer disease, chronic gastritis and cholecystoangiocholitis].
March 1976, Vrachebnoe delo,
Copied contents to your clipboard!